Scientists have discovered important redundancies in T cells
Redundancies have been discovered in the biochemical signalling pathways of immune cells which could impact cancer immunotherapy.
List view / Grid view
Redundancies have been discovered in the biochemical signalling pathways of immune cells which could impact cancer immunotherapy.
Researchers have found an enzyme and its counterpart which inhibit T-cells from attacking tumour cells.
Study raises doubts on a previous theory of Parkinson’s disease...
In an experiment with pigs, researchers have demonstrated for the first time that the administration of even extremely low doses of an endocrine disruptor - in this case, an endogenous oestrogen - leads to epigenetic changes in a pregnant sow’s DNA.
24 May 2018 | By
Scientists in Switzerland have constructed an enzyme than can penetrate a mammalian cell and accelerate the release of a hormone. This then activates a gene switch that triggers the creation of a fluorescent protein.
Researchers have developed a new imaging agent that could help guide and assess treatments for people with various neurological diseases...
Scientists in Switzerland have developed a new means of crystallising membrane proteins – a hitherto elusive feat – in order to study their structure and aid understanding of their processes.
Researchers have systematically analysed and quantified the interactions of all proteins with metabolites on the level of the whole proteome...
Autonomous driving, automatic speech recognition, and the game Go: Deep Learning is generating more and more public awareness.
27 September 2016 | By ETH Zürich
Scientists identified a protein in liver cells, known as vigilin, which regulates the release of fats from the liver into the bloodstream. Find out more...